Ticker: ALKS

Company Overview Alkermes plc (NASDAQ: ALKS) is a global biopharmaceutical company engaged in developing medications for psychiatric and neurological disorders, including treatments for alcohol and opioid dependence, schizophrenia, and bipolar disorder. Recent Developments 1. Income Statement Hig...